Research
Title : | An open label, balanced, randomized clinical trial to evaluate safety & efficacy of piperine 225 mg with standard anti tubercular treatment in newly diagnosed sputum positive drug sensitive pulmonary TB adult patients in comparison with standard .. |
Area of research : | Medical Sciences |
Focus area : | Task Force (TF) |
Principal Investigator : | Mr. R. Sarin, Director, National Institute of Tuberculosis & Respiratory Diseases, Delhi |
Timeline Start Year : | 2019 |
Timeline End Year : | 2022 |
Details
Total Budget (INR): | 25,71,720 |
Organizations involved
Implementing Agency : | National Institute of Tuberculosis & Respiratory Diseases, Delhi |
Funding Agency : | Indian Council of Medical Research (ICMR) |